Protein Kinase B Kinases That Mediate Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Activation of Protein Kinase B

Len Stephens(Babraham Institute), Karen E. Anderson(Babraham Institute), David Stokoe(Babraham Institute), Hediye Erdjument‐Bromage(Babraham Institute), Gavin F. Painter(Babraham Institute), Andrew B. Holmes(Babraham Institute), Piers R. J. Gaffney(Babraham Institute), Colin B. Reese(Babraham Institute), Frank McCormick(Babraham Institute), Paul Tempst(Babraham Institute), John Coadwell(Babraham Institute), Phillip T. Hawkins(Babraham Institute)
Science
January 30, 1998
Cited by 1,061

Abstract

Protein kinase B (PKB) is activated in response to phosphoinositide 3-kinases and their lipid products phosphatidylinositol 3,4, 5-trisphosphate [PtdIns(3,4,5)P3] and PtdIns(3,4)P2 in the signaling pathways used by a wide variety of growth factors, antigens, and inflammatory stimuli. PKB is a direct target of these lipids, but this regulation is complex. The lipids can bind to the pleckstrin homologous domain of PKB, causing its translocation to the membrane, and also enable upstream, Thr308-directed kinases to phosphorylate and activate PKB. Four isoforms of these PKB kinases were purified from sheep brain. They bound PtdIns(3,4,5)P3 and associated with lipid vesicles containing it. These kinases contain an NH2-terminal catalytic domain and a COOH-terminal pleckstrin homologous domain, and their heterologous expression augments receptor activation of PKB, which suggests they are the primary signal transducers that enable PtdIns(3,4,5)P3 or PtdIns- (3,4)P2 to activate PKB and hence to control signaling pathways regulating cell survival, glucose uptake, and glycogen metabolism.


Related Papers

No related papers found

Powered by citation graph analysis